Report: Pfizer would pay $75M in Trovan case

Pfizer has agreed to pay $75 million to settle the long-running Nigerian case over a meningitis drug trial, African news sources report. The trial participants and families who sued will share the settlement with the Kano State Government in Nigeria. It's unclear at press time, however, whether all sides have approved the settlement deal. Report

Suggested Articles

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Novartis hopes to leverage its existing presence in the hematology community to achieve a successful launch of Adakveo.

AstraZeneca's Farxiga is touting its heart failure data in patients with or without diabetes, but results in non-diabetics looks particularly strong.